HALOZYME THERAPEUTICS, INC.: capex
| Value | {"amount": 534000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2013-01-01 – 2013-03-31 |
| Status | current |
| Entity | HALOZYME THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:36:26.700322+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b25c02fd-fdab-4877-abb9-9b0452af934a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001159036-14-000042Retrieved: 2026-08-19T11:36:26.700322+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001159036/capex/2013-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b25c02fd-fdab-4877-abb9-9b0452af934a
History
- supersedes {"amount": 534097, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} (evidence 0001483813-13-000051)